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Abstract 24 
Glaesserella (Haemophilus) parasuis is a commensal of the upper respiratory tract in pigs and 25 
also the causative agent of Glӓsser’s disease, which causes significant morbidity and mortality in 26 
pigs worldwide. Isolates are characterized into 15 serovars by their capsular polysaccharide, 27 
which has shown a correlation to isolate pathogenicity. To investigate the role capsule plays in 28 
G. parasuis virulence and host interaction, a capsule mutant of the serovar 5 strain HS069 was 29 
generated (HS069∆cap) through allelic exchange following natural transformation. HS069∆cap 30 
was unable to cause signs of systemic disease during a pig challenge study and had increased 31 
sensitivity to complement killing and phagocytosis by alveolar macrophages. When compared to 32 
the parent strain, HS069Δcap produced more robust biofilm and adhered equivalently to 3D4/31 33 
cells; however, it was unable to persistently colonize the nasal cavity of inoculated pigs, with all 34 
pigs clearing HS069Δcap by 5 days post-challenge. Our results indicate the importance of 35 
capsular polysaccharide to G. parasuis virulence as well as nasal colonization in pigs.  36 
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Introduction 38 
Glaesserella (Haemophilus) parasuis is the etiologic agent of Glӓsser’s disease in pigs, 39 
which presents as a fibrinous polyserositis, arthritis and meningitis (1, 2). In addition, it can be a 40 
bacterial contributor to swine respiratory disease and is found as a commensal in the nasal cavity 41 
of healthy swine (1). G. parasuis isolates are classified into 15 serovars, based on gene content 42 
and diversity at their capsular polysaccharide loci and via the Kielstein-Rapp-Gabrielson typing 43 
scheme (3, 4). While it appears some serovars are more pathogenic and widespread, serotyping 44 
has shown an incomplete correlation with isolate virulence (3, 5, 6).  45 
The importance of capsular polysaccharide as a virulence factor for encapsulated bacteria 46 
has been investigated (7-10), which indicates the capsule-deficient counterparts to encapsulated 47 
bacteria are much less likely to cause invasive disease and are often reduced to avirulence. The 48 
reduction in virulence seen in capsular mutants has been attributed to the role that capsule plays 49 
in adherence to host tissues and evasion of the host immune response, specifically inhibition of 50 
complement mediated killing and phagocytosis (11). Additionally, there is evidence indicating 51 
capsular polysaccharide is essential for some encapsulated bacteria to colonize the mucous 52 
membranes of hosts (12). 53 
The functions of capsule have been partially evaluated in G. parasuis SH0165, a virulent 54 
serovar 5 strain (10). The capsular mutant (SH0165∆capD) was significantly less virulent than 55 
the wild type bacteria and unable to cause invasive disease in challenged pigs (10). SH0165∆cap 56 
was also highly susceptible to complement mediated killing as compared to the wild type 57 
bacteria (10). This presented evidence for the importance of capsule in causing invasive disease; 58 
however, the characteristics of the capsular mutant were not fully elucidated and the capacity of 59 
SH0165∆cap to colonize the swine nasal cavity was not evaluated. In this study, a capsule 60 
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mutant of G. parasuis HS069 (HS069Δcap), a virulent serovar 5 strain, was used to examine the 61 
in vitro and in vivo characteristics of capsule. We evaluated HS069∆cap for susceptibility to 62 
complement killing, biofilm formation, attachment to porcine macrophage 3D4/31 cells, and 63 
phagocytosis by porcine alveolar macrophages. In addition, swine were challenged with HS069 64 
and HS069Δcap to evaluate virulence, capacity for nasal colonization, and stimulation of host 65 
immunity.  66 
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Materials and Methods 68 
Bacterial isolates  69 
The virulent serovar 5 G. parasuis strain HS069 was isolated from the lung of a pig with clinical 70 
signs of respiratory disease (13). Production and verification of HS069∆cap is described within 71 
the following mutant generation and results sections. G. parasuis strains were grown on brain 72 
heart infusion (BHI) plates or BHI broth (Becton, Dickinson and Company, Franklin Lakes, NJ) 73 
supplemented with 0.1 mg/mL nicotinamide adenine dinucleotide (NAD+) and 10% horse serum 74 
(referred to as BHI+). G. parasuis strains were also grown on chocolate agar, made with 75 
Columbia Blood Agar Base (Thermo Fisher Scientific Inc., Waltham, MA) supplemented 7% 76 
defibrinated horse blood (TCS Bioscience Ltd., Botolph Claydon, England) lysed at 80°C for 10 77 
minutes and 25 µg/mL NAD+. Media were supplemented with chloramphenicol (1 µg/mL) for 78 
selection purposes. All strains were grown at 37oC with 5% CO2. 79 
Escherichia coli strain TOP10 (Invitrogen, Carlsbad, CA) was used as the cloning host. E. coli 80 
was grown in Luria Bertani (LB) broth or agar (Oxoid). Media were supplemented with 81 
ampicillin (100 µg/mL) or chloramphenicol (50 µg/mL) where required for selection.  82 
Mutant construction  83 
DNA manipulation: Genomic DNA extractions were performed using the DNeasy Kit (Qiagen, 84 
Hilden, Germany), plasmid DNA extractions were performed using a plasmid miniprep kit 85 
(Qiagen), and PCRs were performed according to the manufacturers’ protocols with Phusion 86 
High-Fidelity DNA Polymerase mix (New England Biolabs, Ipswich, MA) for cloning and 87 
GoTaq green PCR mix (Promega, Madison, WI) for verification. PCR fragments purified by 88 
QIAquick PCR Purification Kit (Qiagen). Restriction enzymes were obtained from New England 89 
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Biolabs. Plasmid DNA was extracted from the agarose gel using Gel Extraction Kit (Qiagen). 90 
DNA concentrations were measured using a NanoDrop (Bio-Rad Laboratories, Hercules, CA). 91 
Construction of plasmid pGEMT-neuAup-Cm-wzsdn: Plasmid pGEMT-neuAup-cat-wzsdn was 92 
constructed for deletion of the whole capsule gene cluster using a three-step cloning strategy. 93 
First, genomic DNA of G. parasuis isolate HS069 was used as a template to amplify the 94 
upstream and downstream regions flanking the 14-kb capsule locus (14, 15). The 647-bp 95 
upstream region of the neuA gene (neuAup) was amplified using primers P1 and P2 and the 731-96 
bp downstream region of the wzs gene (wzsdn) using primers P3 and P4 (Table 1). In parallel, 97 
the chloramphenicol resistance cassette (Cm), containing the 9-bp DNA uptake signal sequence 98 
(USS) of 5'-ACCGCTTGT (16) was amplified from 50 ng linearized plasmid pUSScat (17) as 99 
the template with primers P5 and P6 (Table 1). Second, PCR products were digested and ligated 100 
into the pGEM-T vector. The PCR product of the upstream region of the neuA gene was digested 101 
with SacI /BamHI and the downstream region of the wzs gene was digested with SalI/ BamHI. 102 
The pGEM-T vector was digested with SacI /SalI. Restricted products were gel purified and 103 
ligated. The constructed plasmid was transformed into E. coli TOP10 and transformants were 104 
confirmed using PCR. After purification, the plasmid pGEMT-neuAup-wzsdn was verified by 105 
Sanger sequencing. Finally, the purified plasmid pGEMT-neuAup-wzsdn and PCR product of 106 
the Cm cassette were subject to BamHI restriction. The gel purified fragments were mixed, 107 
ligated and transformed into E. coli TOP10. The resulting plasmid pGEMT-neuAup-cat-wzsdn 108 
was extracted and confirmed by Sanger sequencing. 109 
Construction of the whole capsule locus deletion mutant Δcap::Cm mutant of G. parasuis 110 
HS069: The plasmid pGEMT-neuAup-cat-wzsdn was linearized with SacI and used to transform 111 
G. parasuis HS069 using natural transformation method as described previously with some 112 
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modifications (18). Briefly, HS069 was grown on chocolate agar overnight and suspended in 113 
BHI broth to achieve an OD660 = 2. Then, a 20 μl aliquot of a 1/10 dilution of the suspension was 114 
spread in a 10 mm area on prewarmed chocolate agar and 20 μl of 8 mM cAMP and 10 μl of 115 
donor DNA in TE buffer were added and mixed with the bacterial cells. The mixture was 116 
incubated at 37ºC overnight. Bacterial cells were scraped up, suspended in 300 μl BHI broth, and 117 
plated onto chocolate agar with 1 ug/mL chloramphenicol. After incubation at 37ºC for 2 days, 118 
suspected transformants were verified using PCR. For negative control, 10 μl of TE buffer 119 
without donor DNA was added to a bacterial spot. The deletion was also confirmed by whole 120 
genome sequencing using the Illumina HiSeq 250 platform and PacBio RS II Resequencing 121 
protocol of the SMRT Analysis software v.2.3.0. Assembly of the PacBio generated HS069 wild 122 
type was done using HGAP (19), circularized using Circlator v.1.1.3 (20), and polished using 123 
Quiver v.1. The Illumina reads were subsequently mapped onto the PacBio assembly to correct 124 
small indels. Comparison of HS069∆cap against the wild type was made by mapping the 125 
Illumina and PacBio reads of HS069∆cap against the finished HS069 wild type assembly.  126 
Transmission electron microscopy (TEM) for capsule visualization 127 
Capsule was visualized via transmission electron microscopy (TEM) using previously described 128 
methods (21-23). Briefly, G. parasuis grown on BHI+ plates overnight were suspended in 0.1 M 129 
cacodylate buffer with 2.5% glutaraldehyde and 0.1% ruthenium red and incubated for 2 hours at 130 
room temperature. Bacteria were pelleted and resuspended in 0.1 M cacodylate buffer with 2.5% 131 
glutaraldehyde and 1.0 mg/mL of polycationic ferritin and incubated for 30 minutes at room 132 
temperature. Bacteria were washed three times in 0.1 M cacodylate buffer. After staining with 133 
ruthenium red and ferritin, samples were post-fixed with 2% osmium tetroxide and rinsed three 134 
times in 0.1 M cacodylate buffer. The samples were processed through graded ethanols, 135 
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propylene oxide, and embedded in Eponate 12 (Ted Pella Inc., Redding, CA). Following a 48 136 
hour polymerization, thin sections were taken and stained with 4% uranyl acetate and Reynolds’ 137 
lead stain. Sections were examined with a FEI Tecnai G2 BioTWIN electron microscope (FEI 138 
Co., Hillsboro, OR).  139 
Growth kinetics 140 
Growth kinetics of G. parasuis HS069 and HS069∆cap were evaluated using a GeneQuant Pro 141 
spectrophotometer (Amersham PLC, Little Chalfont, United Kingdom). G. parasuis isolates 142 
were inoculated from a liquid overnight culture into BHI+ broth at an OD600 of 0.05. The 143 
cultures were incubated at 37ºC with 5% CO2 and shaking at 200 RPM. OD600 readings were 144 
taken hourly for 8 hours. 145 
Biofilm assay using microtiter plate 146 
The microtiter plate assay for biofilm formation was adapted from a protocol described by Cassat 147 
et al. (24). Overnight cultures of G. parasuis were adjusted to an initial OD600 of 0.05, 0.125, or 148 
0.25 in BHI+ broth. Diluted G. parasuis was plated in triplicate on a Nunc 96-well flat bottom 149 
plate (Thermo Fisher Scientific Inc., Waltham, MA) and incubated statically for 48 hours at 37oC 150 
with 5% CO2. Cultures were gently removed from the plate and washed three times with sterile 151 
PBS. Biofilm was fixed with 100% ethanol, allowed to dry for 10 minutes, and stained with 152 
0.1% crystal violet. After 15 minutes at room temperature, plates were washed gently three times 153 
with PBS and allowed to dry overnight. Crystal violet was eluted from the biofilm with 150 uL 154 
of 100% ethanol for 10 minutes. The elution (120 uL) was transferred to a new 96 well plate and 155 
absorbance measured at 538 nm with a SpectraMax M5 (Molecular Devices, LLC, Sunnyvale, 156 
CA). Three independent replicates were performed.  157 
Complement mediated killing 158 
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To assess sensitivity to complement mediated killing, G. parasuis cultures were treated with 159 
guinea pig serum (GPS) (Quidel, San Diego, CA). Heat inactivated GPS (30 minutes at 56ºC) 160 
was used as a negative control. G. parasuis cultures were grown on BHI+ plates and suspended 161 
in PBS to reach an OD600 of 0.42 (1x108 bacteria/mL). In a 96-well plate, 90 uL of GPS was 162 
added to 10 uL of G. parasuis (approximately 106 CFU). The G. parasuis and GPS incubated for 163 
1 hour at 37ºC, 5% CO2, 100 rpm shaking. Serial dilutions were plated on BHI+ plates.  164 
Adherence capacity to porcine alveolar macrophage cell line (3D4/31 cells) 165 
The interaction of G. parasuis HS069 and HS069∆cap with porcine alveolar macrophages was 166 
tested in vitro using the 3D4/31 cell line (ATCC, Manassas, VA). 3D4/31 cells were maintained 167 
in complete Advanced RPMI 1640 (Thermo Fisher Scientific Inc., Waltham, MA) as per 168 
ATCC’s recommendations. For the assay, 3D4/31 cells were plated into 4-well chamber slides 169 
(ibidi USA Inc., Madison, WI) at 5x105 cells/mL and allowed to adhere overnight. G. parasuis 170 
HS069 and HS069∆cap were added to the chambers to obtain an MOI of 10:1 and incubated for 171 
1 hour at 37ºC and 5% CO2. After incubating, 3D4/31 cells were washed to remove non-adherent 172 
bacteria and chamber slides were placed on ice. G. parasuis cells were incubated with mouse 173 
monocolonal antibody to the outer membrane protein P5 (provided by M. Gottschalk) for 30 174 
minutes at 4ºC followed by incubation with goat anti-mouse IgG3 (SouthernBiotech, 175 
Birmingham, AL) for 30 minutes at 4ºC. Cells were fixed with ice cold 50:50 methanol:acetone 176 
for 10 minutes and dried. Images were taken using Nikon AR1+Si confocal microscope and 177 
evaluated using the NIS Elements software (Nikon Instruments Inc., Melville, NY). Bacterial 178 
intensity was evaluated using 10 random views. 179 
Phagocytosis assessment using primary porcine alveolar macrophages 180 
Porcine alveolar macrophages (PAMs) were isolated as previously described (25, 26), with 181 
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modifications. Briefly, the lungs of healthy pigs were flushed with PBS repeatedly until around 182 
250 mL of fluid was collected. The lavage fluid was centrifuged at 1000 RPM for 10 minutes. 183 
The pellet was washed twice and resuspended in complete RPMI-1640 medium (10% fetal 184 
bovine serum, 1 µg/mL fungizone, 100 U/mL penicillin, and 100 µg/mL streptomycin). PAMs 185 
were allowed to adhere to petri dishes for 2 hours at 37º C with 5% CO2. After 2 hours, media 186 
and non-adherent cells were aspirated and adherent cells were washed with complete RPMI. 187 
Adherent cells were removed via cell scraping, washed twice with PBS, and resuspended in 188 
RPMI without antibiotics. Cells were counted and scored for viability using the Countess II 189 
Automated Cell Counter (Invitrogen, Carlsbad, CA). PAMs were plated into 48-well plates with 190 
5x105 PAMs per well and allowed to adhere for 20 minutes prior to starting the assay. 191 
Bacterial stocks were generated by suspending agar grown HS069 and HS069∆cap in 192 
PBS with 50% glycerol at an OD600 of 0.42. The stocks were quantified via serial dilution and 193 
frozen at -80º C until use. HS069 or HS069∆cap stocks were diluted to obtain an MOI of 10:1 in 194 
250 µL total volume per well (approximately 5x106 CFU/well).  195 
To assess phagocytosis, the media was aspirated and RPMI containing G. parasuis was 196 
added to each well. The PAMs were incubated with the bacteria for 1 or 2 hours and the 197 
supernatant was used to quantify non-phagocytosed bacteria. PAMs were isolated from four 198 
different animals and 2-4 replicates were completed per animal for each isolate. The CFU/mL 199 
was quantified for HS069 and HS069∆cap inocula. The log fold reduction was calculated by 200 
subtracting the remaining bacteria at hour 1 or 2 from the initial inoculum. 201 
G. parasuis challenge 202 
All experiments were approved by the National Animal Disease Center’s Institutional Animal 203 
Care and Use Committee. Caesarian-derived, colostrum-deprived (CDCD) pigs were derived at 204 
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the National Animal Disease Center. At 4 weeks of age, pigs were intranasally challenged with 2 205 
mL (1 mL per nostril) of 1x108 CFU/mL G. parasuis HS069 (4 pigs) or HS069Δcap (5 pigs) 206 
suspended in PBS. Pigs were monitored for clinical signs (lameness, respiratory distress, 207 
lethargy, neurologic signs) and humanely euthanized when systemic signs of disease were noted. 208 
At necropsy, gross lesions were recorded and serum, nasal swabs, serosal swabs, joint fluid, lung 209 
lavage, and cerebral spinal fluid samples were obtained and plated for CFU counts. Serum and 210 
nasal swab samples were taken on day 0 and day 21 post-challenge. To investigate the vaccine 211 
potential of HS069Δcap, the pigs surviving challenge with HS069Δcap (5 pigs) were intranasally 212 
challenged with 2 mL (1 mL per nostril) of 1x108 of G. parasuis HS069 wild type on day 21 213 
post-challenge with HS069Δcap. Pigs were monitored and treated as described above 214 
A follow up study was conducted to evaluate nasal colonization of HS069Δcap in CDCD 215 
pigs. At 6 weeks of age, 6 pigs were inoculated intranasally with 2 mL (1 mL per nostril) of 216 
1x108 CFU/mL suspension of G. parasuis HS069Δcap in PBS. Nasal swabs were obtained on 217 
day 0, 1, 3, 5, 7, and 14 post-challenge for G. parasuis detection. G. parasuis species specific 218 
PCR was run on these samples to detect bacterial colonization utilizing the primer set described 219 
by Howell et al. (27). Briefly, DNA was extracted from 50 μL of nasal swab samples using the 220 
MagMAX Pathogen RNA/DNA Kit (Thermo Fisher Scientific Inc., Waltham, MA). Extracted 221 
DNA was screened as previously described using G. parasuis species specific primers: 222 
HPS_219690793-F (5’-ACAACCTGCAAGTACTTATCGGGAT-3’) and HPS_219690793-R 223 
(5’-TAGCCTCCTGTCTGATATTCCCACG-3’) (27). 224 
ELISA for serum antibody titer 225 
Nunc MaxiSorp plates (Thermo Fisher Scientific Inc., Waltham, MA) were coated with 0.5 226 
mg/mL of HS069Δcap sonicate in 100 mM carbonate-bicarbonate buffer (pH 9.6) at 4ºC 227 
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overnight. Plates were washed with 0.05% Tween 20 in PBS (PBST) followed by blocking for 1 228 
hour at 37ºC with 2% bovine serum albumin (BSA) in PBST. After washing with PBST, serum 229 
samples were serially diluted in 1% BSA/PBST and applied to wells for 2 hours at 37ºC. Plates 230 
were washed with PBST and HRP-conjugated secondary goat anti-swine IgG antibody (SeraCare 231 
Life Sciences, Milford, MA) was diluted 1:50,000 in 1% BSA/PBST added and incubated for 1 232 
hour at 37ºC. ELISAs were developed using tetramethylbenzidine (TMB) substrate (Thermo 233 
Fisher Scientific Inc., Waltham, MA). TMB was added to each well, incubated at room 234 
temperature for 15 minutes, and the reaction halted with sulfuric acid (2 N). Absorbance 450 nm 235 
was measured on a SpectraMax M5 (Molecular Devices, LLC, Sunnyvale, CA). 236 
Statistical analysis 237 
Statistical analysis was completed using GraphPad Prism 7.03 (GraphPad Software, La Jolla, 238 
CA). Biofilm formation was compared using an unpaired t test. Complement mediated killing 239 
was evaluated as a log-fold reduction in G. parasuis between heat inactivated GPS and GPS and 240 
analyzed using an unpaired t test. Phagocytosis was evaluated using log-fold reduction in G. 241 
parasuis between the inoculum and PAM incubated wells. The difference in reduction between 242 
HS069 and HS069∆cap was compared using an ordinary one-way ANOVA. Comparison of 243 
adherence to porcine alveolar macrophages was completed using unpaired t tests comparing both 244 
bacterial cells per 3D4/31 cell and fluorescent intensity per 3D4/31 cell. Welch’s corrections 245 
were used to account for differences in standard deviation when necessary. Results were 246 
considered significant at a p-value of p < 0.05. 247 
  248 
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Results 249 
Development and confirmation of HS069 capsule mutant 250 
The capsule locus of HS069 was removed by deleting the sequence from neuA_3 to etk 251 
(alternatively wzc or wzs) (Figure 1-A), which removed the biosynthesis and glycosyltransferase 252 
proteins contained within the serovar 5 capsule locus. The deleted sequence was confirmed with 253 
whole genome sequencing using the PacBio sequencing platform. When the wild type and 254 
HS069∆cap genomes were compared, no HS069∆cap reads mapped to the region of the capsule 255 
locus (Figure 1-B). 256 
Transmission electron microscopy (TEM) was also performed to phenotypically confirm 257 
the deletion of the capsule locus. In Figure 2, the surface of the HS069 wild type cells is irregular 258 
and thickened as compared to HS069Δcap. This confirmed the absence of capsular 259 
polysaccharide of the cell surface of HS069∆cap. 260 
Growth characteristics and cellular morphology 261 
Comparison of the growth kinetics of G. parasuis HS069 and HS069Δcap grown in BHI+ broth 262 
indicated there was no alteration in cellular proliferation associated with deletion of the capsule 263 
locus (Supplemental Figure 1).  264 
Biofilm formation 265 
Evaluation of static biofilm production indicated similar capacity for G. parasuis isolates to 266 
produce biofilm at all starting cell densities tested (0.05, 0.125, and 0.25) (data not shown). 267 
Statistical evaluation of static biofilm production by HS069 and HS069Δcap grown from an 268 
initial cell density of 0.05 indicated a significant enhancement in production associated with loss 269 
of capsular polysaccharide production (p = 0.0193) (Figure 3). 270 
Complement mediated killing 271 
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Sensitivity to complement mediated killing (serum sensitivity) was evaluated using non-treated 272 
and heat inactivated GPS. A significant increase in sensitivity to complement killing was noted 273 
for HS069Δcap as compared to wild type HS069 (p = 0.0207) (Figure 4).  274 
Adherence capacity to porcine alveolar macrophage cell line 275 
Confocal microscopy was used to evaluate the adherence capacity of HS069 and HS069Δcap to 276 
porcine alveolar macrophages (3D4/31 cells). A distinct difference in the pattern of attachment 277 
was visualized between HS069 and HS069Δcap (Figure 5), with HS069Δcap producing 278 
aggregates of bacteria (Figure 6B) that were not noted with HS069 wild type (Figure 6A). 279 
Because of the aggregation of HS069Δcap, adherence was evaluated both as a bacterial count per 280 
3D4/31 cell and fluorescent intensity per 3D4/31 cell. There was no statistically significant 281 
difference in adherence capacity when HS069 and HS069Δcap were compared for bacterial 282 
counts (p = 0.0594) or compared for fluorescent intensity (p = 0.4296).  283 
Phagocytosis by primary porcine alveolar macrophages 284 
Changes in susceptibility to phagocytosis were assessed by incubation with isolated primary 285 
porcine alveolar macrophages. After one hour of incubation, there was no difference in 286 
phagocytosis between HS069 and HS069∆cap (P = 0.93); however, after two hours of 287 
incubation, significantly more HS069∆cap were phagocytosed compared with HS069 wild type 288 
(P < 0.01) (Figure 7). 289 
Virulence assessment 290 
To assess the virulence of HS069Δcap as compared to the parent strain, a total of 11 CDCD pigs 291 
were challenged with HS069Δcap and four with wild type HS069. The parent strain resulted in 292 
100% mortality by day 2 post-challenge, while animals challenged with HS069Δcap showed no 293 
clinical signs of G. parasuis infection and survived until the end of the study (20 days post-294 
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challenge).  295 
Colonization and immune stimulation 296 
A second study was conducted to evaluate nasal colonization of HS069Δcap in CDCD pigs. The 297 
presence of G. parasuis in nasal wash samples was assessed by PCR. Species specific primers 298 
detected G. parasuis on days 1 (1 pig) and 3 (2 pigs) post-challenge; however, all pigs were 299 
negative by PCR by day 5 post-challenge.  300 
Serum antibody titer for animals challenged with HS069Δcap was determined at day 0, 7, 301 
14, and 21 post-challenge (Figure 8). A mild increase in serum antibody to HS069Δcap sonicate 302 
was seen over the study period with the average Log10 titer rising from 3.121±0.336 to 303 
3.572±0.250. However, upon intranasal challenge of HS069Δcap inoculated animals with wild 304 
type G. parasuis HS069, all animals succumbed to disease by 3 days post challenge.  305 
  306 
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Discussion 307 
Capsular polysaccharide is an important factor for the survival and virulence of many bacteria. It 308 
is known to function in adhesion and immune evasion through resistance to complement killing 309 
and phagocytosis (11). In this study, we sought to better evaluate the function of capsule for G. 310 
parasuis, the causative agent of Glӓsser’s Disease in pigs. Capsule has been correlated with 311 
virulence, with some serovars associated with disease and others with nasal colonization (3, 5, 312 
6). The importance of capsule for G. parasuis was previously investigated in the serovar 5 strain 313 
SH0165 (10). Wang and colleagues found SH0165ΔcapD to be less serum resistant and non-314 
virulent in a pig challenge, compared to the highly virulent parent strain (10). To confirm and 315 
expand on these findings and better understand how capsule contributes to G. parasuis disease, 316 
we generated a capsular mutant of the virulent serovar 5 strain HS069 followed by evaluation of 317 
sensitivity to complement killing and macrophage adhesion in vitro as well as virulence, 318 
colonization, and immune stimulation in vivo.  319 
Here, the virulence of HS069Δcap was assessed with a combination of in vitro assays and 320 
an in vivo challenge. We found that, similar to previous reports, HS069Δcap was markedly less 321 
virulent in a pig challenge than the encapsulated parent strain. This confirmed what was noted by 322 
Wang and colleagues with SH0165Δcap (10). Reduced virulence of capsule deficient isolates has 323 
been attributed in part to the marked increase in serum sensitivity in non-encapsulated G. 324 
parasuis strains, which was seen with both HS069Δcap (Figure 4) and SH0165Δcap (10). 325 
Resistance to complement killing enables bacteria that penetrate mucosal defenses to better 326 
survive and disseminate to systemic sites, such as the central nervous system, joints, and serosal 327 
surfaces, as seen in G. parasuis infection. 328 
Virulence has also been correlated with susceptibility to porcine alveolar macrophages 329 
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(28), which serve as the first line of defense during pulmonary infection. To investigate the 330 
interaction between HS069Δcap and porcine alveolar macrophages, we examined the adherence 331 
capacity of HS069Δcap and the parent strain to 3D4/31 cells (Figure 6). In this investigation, 332 
HS069 and HS069Δcap adhered equivalently, indicating the capsule is not playing a role in the 333 
interaction between G. parasuis HS069 and 3D4/31 cells. This analysis was made more 334 
complicated by the aggregation of HS069Δcap (Figure 5); however, through analysis of 335 
fluorescent intensity, we were able to account for aggregated bacteria (Figure 6B). We also 336 
evaluated HS069 and HS069∆cap for susceptibility to phagocytosis by primary PAMs, which 337 
revealed significantly more HS069∆cap was phagocytosed over two hours than HS069 wild 338 
type. This indicates the importance of G. parasuis capsule in protection against macrophage 339 
phagocytosis, which has not been shown previously in G. parasuis. 340 
Additionally, we investigated the persistence of G. parasuis HS069Δcap in the nasal 341 
passageways, which indicated the importance of capsular polysaccharide not just in systemic 342 
infection, but also to colonization. Though biofilm production was enhanced for HS069Δcap 343 
(Figure 3), it did not contribute to persistent nasal colonization and HS069Δcap was cleared from 344 
all pigs in the second study by 5 days post-inoculation. This contrasts with colonization of the 345 
parent strain, which can persist in the nasal tract of vaccinated pigs (4/5 animals) through 11 346 
days post-challenge (data not shown). Previous results assessing the role of capsule in 347 
colonization and adherence of other bacterial species have conflicted, with some studies 348 
reporting deficient colonization seen with capsular mutants and others indicating an increased 349 
capacity for adhesion to cell lines in vitro (12, 29-32). It has been hypothesized that the absence 350 
of capsule may increase the exposure of surface adhesins that contribute to adherence in vitro; 351 
however, most studies evaluated only in vitro adherence and have not investigated the effect of 352 
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capsule in colonization in vivo. Our findings in this study indicate capsule may play a significant 353 
role in persistent colonization with G. parasuis in vivo, similar to that seen previously with 354 
Streptococcus pneumoniae (12). 355 
The lack of virulence seen with G. parasuis capsular mutants would potentially make 356 
them a good candidate for an attenuated live vaccine; however, our investigation showed only a 357 
mild increase in G. parasuis serum antibody titer over the 21 day study period (Figure 8) with an 358 
average Log10 titer at 21 days post-inoculation of 3.572±0.250. The titers seen in animals 359 
inoculated with HS069∆cap are low when compared with other studies in which animals were 360 
vaccinated with a single dose HS069 bacterin (average Log10 titer 21 days post vaccination 361 
4.221±0.377) or after boost vaccination (average Log10 day 42 titer 4.752±0.190), which has 362 
shown protection against homologous challenge. Low titers associated with HS069∆cap are 363 
likely due to its rapid clearance from the nasal cavity, which would limit interaction with 364 
immune cells and development of an adaptive immune response. Furthermore, when pigs 365 
inoculated with HS069Δcap were challenged with the parent strain, we saw no protection from 366 
G. parasuis disease, indicating the antibody response generated was not protective.  367 
It is important to note, this evaluation of the importance of capsule in G. parasuis 368 
colonization and infection involved the generation and use of a mutant deficient in all genes of 369 
the capsule locus. Because of this, we cannot eliminate the possibility that there are alternative 370 
functions for genes within the capsule locus that may be contributing to the phenotypes we 371 
observed in this study. Additionally, because of the size of the capsule locus, a mutant 372 
complemented with the deleted genes was not generated and comparisons can only be made 373 
between the wild type and the mutant. 374 
Conclusions 375 
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This investigation of the G. parasuis capsule mutant HS069∆cap confirms the importance 376 
of capsule to a fully virulent phenotype in vivo that has been seen previously with 377 
SH0615∆capD. Capsular polysaccharide plays an important role in resistance to complement 378 
killing and phagocytosis, which may be a key factor in the dissemination of G. parasuis during 379 
infection to systemic sites. In this study, we also found capsule to be an essential factor in G. 380 
parasuis HS069 for persistent colonization of the swine nasal cavity. However, because of the 381 
rapid clearance of HS069Δcap from the nasal cavity, generation of antibody was minimal and no 382 
protection was provided against challenge with the parent strain making HS069Δcap a poor 383 
modified live vaccine candidate. 384 
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Primer Sequence (5’-3’)a 
SH0165 
genome (15) 
P1 (neuAupFor1) AAGACTGAGCTCTCGTTTTCCAGACAGCAATG 49398-49417 
P2 (neuAupRev1) AAGACTGGATCCCTCCTTTACATGCCCCCATC 50044-50025 
P3 (wzsDnFor1) AAGACTGGATCCTTGATGTAAGCGGTGGGATT 64033-64052 
P4 (wzsDnRev1) AAGCGAGTCGACAGTTGCGGCATAATCCAAAT 64763-64744 
P5 (catFor) GCGATGGATCCTGTGGAATTGTGAGCGGATA n/a 
P6 (catRev) GCGATGGATCCACAAGCGGTTTCAACTAACGG n/a 
Table 1: Primers utilized in the construction of HS069∆cap. 513 
a Restriction sites are underlined, BamHI: GGATCC, SalI: GTCGAC and SacI: GAGCTC.  514 
 515 
Figure 1. Capsule locus deletion and verification. The entirety of the capsule locus was 516 
deleted from neuA_3 to etk as indicated (A). The loss of the capsule locus was verified using 517 
Artemis Compare Tool (B). No sequence reads mapped to the region of the capsule locus. 518 
 519 
Figure 2. Transmission electron microscopy visualization of capsule. The capsule layer of G. 520 
parasuis HS069 wild type (A) and HS069Δcap (B) were visualized using transmission electron 521 
microscopy to verify HS069Δcap was deficient in capsular polysaccharide production. The 522 
surface of HS069Δcap lacked thickened, irregular surface associated with capsule production. 523 
 524 
Figure 3. Biofilm production by HS069 wild type and HS069∆cap. The capacity of G. 525 
parasuis HS069 and HS069∆cap to produce biofilm under static growth conditions was 526 
quantified using microtiter assays. Results here represent data from replicates with a starting 527 
OD600 of 0.05. The average absorbance at 538nm is shown (column) with standard deviation 528 
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indicated (error bars). Statistical significance is indicated by the asterisk (*) at a level of p < 0.05. 529 
 530 
Figure 4. Evaluation of sensitivity to complement killing. G. parasuis HS069 and HS069∆cap 531 
were screened for resistance to complement mediated killing. Statistical analysis of the log10 532 
reduction in CFU/mL was analyzed and statistical significance is indicated by the asterisk (*) at 533 
a level of p < 0.05. 534 
 535 
Figure 5. Adherence capacity of HS069 and HS069Δcap to 3D4/31 cells.  The capacity for 536 
HS069 and HS069Δcap to adhere to porcine alveolar macrophages was evaluated using the 537 
3D4/31 cell line. The interaction between G. parasuis and 3D4/31 cells was evaluated by 538 
confocal microscopy in chamber slides. G. parasuis strains were stained using a monocolonal 539 
antibody to the outer membrane protein P5. Bacterial aggregates were noted when evaluating 540 
HS069Δcap (B), but were not produced by the wild type HS069 isolate. 541 
 542 
Figure 6. Adherence capacity to porcine alveolar macrophages (3D4/31 cell line). The 543 
capacity of G. parasuis HS069 and HS069∆cap to adhere to porcine alveolar macrophages was 544 
evaluated using the 3D4/31 cell line. Due to the clusters of bacterial cells noted using confocal 545 
microscopy, adherence was evaluated both as bacterial cells detected per 3D4/31 cell (A) and 546 
fluorescent intensity per 3D4/31 cell (B). No statistical differences were noted in bacteria per cell 547 
or fluorescent intensity per cell. 548 
 549 
Figure 7. Evaluation of susceptibility to phagocytosis. G. parasuis HS069 and HS069∆cap 550 
were screened for susceptibility to phagocytosis using porcine alveolar macrophages. Log fold 551 
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reduction in G. parasuis [log10(CFU/mL)] is represented for both time points (1 hour and 2 hour 552 
incubation). The reduction of G. parasuis HS069 and HS069∆cap was not statistically different 553 
after 1 hour of incubation (P = 0.93); however, after 2 hours of incubation with PAMs 554 
significantly more G. parasuis HS069∆cap was phagocytosed than HS069 wild type (P < 0.01). 555 
 556 
Figure 8. Serum antibody titers for pigs inoculated with HS069Δcap. The serum antibody 557 
titer was detected using an ELISA to whole cell sonicate. The data presented in this graph 558 
represent the animals in the second study investigating colonization with HS069Δcap.  559 
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